|
1
|
Flynn JL: Immunology of tuberculosis and
implications in vaccine development. Tuberculosis (Edinb).
84:93–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu PT, Stenger S, Li H, Wenzel L, Tan BH,
Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al: Toll-like
receptor triggering of a vitamin D-mediated human antimicrobial
response. Science. 311:1770–1773. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Talat N, Perry S, Parsonnet J, Dawood G
and Hussain R: Vitamin D deficiency and tuberculosis progression.
Emerg Infect Dis. 16:853–855. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zignol M, van Gemert W, Falzon D,
Sismanidis C, Glaziou P, Floyd K and Raviglione M: Surveillance of
anti-tuberculosis drug resistance in the world: An updated
analysis, 2007–2010. Bull World Health Organ. 90:111–119D. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goswami R, Mishra SK and Kochupillai N:
Prevalence & potential significance of vitamin D deficiency in
Asian Indians. Indian J Med Res. 127:229–238. 2008.PubMed/NCBI
|
|
6
|
Holick MF: Vitamin D deficiency. N Engl J
Med. 357:266–281. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Querfeld U: Vitamin D and inflammation.
Pediatr Nephrol. 28:605–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dusso AS, Brown AJ and Slatopolsky E:
Vitamin D. Am J Physiol Renal Physiol. 289:F8–F28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pike JW and Meyer MB: The vitamin D
receptor: New paradigms for the regulation of gene expression by
1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am. 38:13–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb
DK, Yoon D, Kong J, Thadhani R and Li YC: 1,25-Dihydroxyvitamin D
promotes negative feedback regulation of TLR signaling via
targeting microRNA-155-SOCS1 in macrophages. J Immunol.
190:3687–3695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Von Essen MR, Kongsbak M, Schjerling P,
Olgaard K, Ødum N and Geisler C: Vitamin D controls T cell antigen
receptor signaling and activation of human T cells. Nat Immunol.
11:344–349. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rook GA, Steele J, Fraher L, Barker S,
Karmali R, O'Riordan J and Stanford J: Vitamin D3, gamma
interferon, and control of proliferation of Mycobacterium
tuberculosis by human monocytes. Immunology. 57:159–163.
1986.PubMed/NCBI
|
|
13
|
Bikle DD: Vitamin D and the immune system:
Role in protection against bacterial infection. Curr Opin Nephrol
Hypertens. 17:348–352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Veldman CM, Cantorna MT and DeLuca HF:
Expression of 1,25-dihydroxyvitamin D (3) receptor in the immune
system. Arch Biochem Biophys. 374:334–338. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miziara ID, Magalhaes AT, Santos M, Gomes
EF and Oliveira RA: Research ethics in animal models. Braz J
Otorhinolaryngol (Article in English, Portuguese). 78:128–131.
2012. View Article : Google Scholar
|
|
16
|
Wu SY, Chen WH, Hsieh CL and Lin YW:
Abundant expression and functional participation of TRPV1 at
Zusanli acupoint (ST36) in mice: Mechanosensitive TRPV1 as an
‘acupuncture-responding channel’. BMC Complement Altern Med.
14:962014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang Z, Xie Y, Dominguez JA, Breed ER,
Yoseph BP, Burd EM, Farris AB, Davidson NO and Coopersmith CM:
Intestine-specific deletion of microsomal triglyceride transfer
protein increases mortality in aged mice. PLoS One. 9:e1018282014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
https://www.nc3rs.org.uk/arrive-guidelines
|
|
19
|
Zeng Y and Liu J: Role of glypican-1 in
endothelial NOS activation under various steady shear stress
magnitudes. Exp Cell Res. 348:184–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng Y, Yao X, Liu X, He X, Li L, Liu X,
Yan Z, Wu J and Fu BM: Anti-angiogenesis triggers exosomes release
from endothelial cells to promote tumor vasculogenesis. J
Extracellular Vesicles. 8:16298652019. View Article : Google Scholar
|
|
21
|
Gibney KB, MacGregor L, Leder K, Torresi
J, Marshall C, Ebeling PR and Biggs BA: Vitamin D deficiency is
associated with tuberculosis and latent tuberculosis infection in
immigrants from Sub-Saharan Africa. Clin Infect Dis. 46:443–446.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang SJ, Wang XH, Liu ZD, Cao WL, Han Y,
Ma AG and Xu SF: Vitamin D deficiency and the risk of tuberculosis:
A meta-analysis. Drug Des Devel Ther. 11:91–102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Penna G and Adorini L: 1
Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation,
activation, and survival of dendritic cells leading to impaired
alloreactive T cell activation. J Immunol. 164:2405–2411. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mosmann TR, Cherwinski H, Bond MW, Giedlin
MA and Coffman RL: Two types of murine helper T cell clone. I.
Definition according to profiles of lymphokine activities and
secreted proteins. J Immunol. 136:2348–2357. 1986.PubMed/NCBI
|
|
25
|
Lichtner M, Rossi R, Mengoni F, Vignoli S,
Colacchia B, Massetti AP, Kamga I, Hosmalin A, Vullo V and
Mastroianni CM: Circulating dendritic cells and interferon-alpha
production in patients with tuberculosis: Correlation with clinical
outcome and treatment response. Clin Exp Immunol. 143:329–337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dominguez J, De Souza-Galvao M,
Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, Milà C, Jiménez MA,
Blanco S, Maldonado J, et al: T-cell responses to the mycobacterium
tuberculosis-specific antigens in active tuberculosis patients at
the beginning, during, and after antituberculosis treatment. Diagn
Microbiol Infect Dis. 63:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Infante-Duarte C and Kamradt T: Th1/Th2
balance in infection. Springer Semin Immunopathol. 21:317–338.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He XY, Xiao L, Chen HB, Hao J, Li J, Wang
YJ, He K, Gao Y and Shi BY: T regulatory cells and Th1/Th2
cytokines in peripheral blood from tuberculosis patients. Eur J
Clin Microbiol Infect Dis. 29:643–650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nemeth J, Winkler HM, Boeck L, Adegnika
AA, Clement E, Mve TM, Kremsner PG and Winkler S: Specific cytokine
patterns of pulmonary tuberculosis in Central Africa. Clin Immunol.
138:50–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Handzel ZT, Barak V, Altman Y, Bibi H,
Lidgi M, Iancovici-Kidon M, Yassky D and Raz M: Increased Th1 and
Th2 type cytokine production in patients with active tuberculosis.
Isr Med Assoc J. 9:479–483. 2007.PubMed/NCBI
|
|
31
|
Flynn JL, Goldstein MM, Triebold KJ, Sypek
J, Wolf S and Bloom BR: IL-12 increases resistance of BALB/c mice
to mycobacterium tuberculosis infection. J Immunol. 155:2515–2524.
1995.PubMed/NCBI
|
|
32
|
Tissandié E, Guéguen Y, Lobaccaro JM,
Aigueperse J and Souidi M: Vitamin D: Metabolism, regulation and
associated diseases. Med Sci (Paris). 22:1095–1100. 2006.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nebbioso M, Buomprisco G, Pascarella A and
Pescosolido N: Modulatory effects of 1,25-dihydroxyvitamin D3 on
eye disorders: A critical review. Crit Rev Food Sci Nutr.
57:559–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Boonstra A, Barrat FJ, Crain C, Heath VL,
Savelkoul HF and O'Garra A: 1α,25-Dihydroxyvitamin D3 has a direct
effect on naive CD4+ T Cells to enhance the development
of Th2 cells. J Immunol. 167:4974–4980. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gregori S, Casorati M, Amuchastegui S,
Smiroldo S, Davalli AM and Adorini L: Regulatory T cells induced by
1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment
mediate transplantation tolerance. J Immunol. 167:1945–1953. 2001.
View Article : Google Scholar : PubMed/NCBI
|
